CEFIXIME DISK SUSCEPTIBILITY TEST CRITERIA

被引：32

作者：

FUCHS, PC ^{[1
]}

BARRY, AL ^{[1
]}

JONES, RN ^{[1
]}

机构：

[1] CLIN MICROBIOL INST,TUALATIN,OR 97062

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 1986年 / 24卷 / 04期

关键词：

D O I：

10.1128/JCM.24.4.647-649.1986

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

收藏

页码：647 / 649

页数：3

相关论文

共 5 条

[1] INVITRO EVALUATION OF CEFIXIME (FK027, FR17027, CL284635) - SPECTRUM AGAINST RECENT CLINICAL ISOLATES, COMPARATIVE ANTIMICROBIAL ACTIVITY, BETA-LACTAMASE STABILITY, AND PRELIMINARY SUSCEPTIBILITY TESTING CRITERIA [J].

FUCHS, PC ;

JONES, RN ;

BARRY, AL ;

THORNSBERRY, C ;

AYERS, LW ;

GAVAN, TL ;

GERLACH, EH .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 5 (02) :151-162

[2] INVITRO AND INVIVO ANTIBACTERIAL PROPERTIES OF FK-027, A NEW ORALLY ACTIVE CEPHEM ANTIBIOTIC [J].

KAMIMURA, T ;

KOJO, H ;

MATSUMOTO, Y ;

MINE, Y ;

GOTO, S ;

KUWAHARA, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) :98-104

[3] COMPARATIVE INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF FR-17027, A NEW ORALLY ACTIVE CEPHALOSPORIN [J].

NEU, HC ;

CHIN, NX ;

LABTHAVIKUL, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :174-180

[4]

1984, M2A3 NAT COMM CLIN L

[5]

1985, M7A NAT COMM CLIN LA